London researchers have developed a three-pronged strategy to tackle pancreatic cancer by combining a drug and viruses that target cancer cells with immune cells from the patients, modified to specifically attack pancreatic cancer cells.

In 10 seconds? Scientists have reported positive preliminary results in lab mice with pancreatic cancer using a combination of a drug, genetically engineered viruses and immune cells.

Continue reading

Try our 7-day free trial and access the full article with citations and resources.

Try For Free Already have an account? Sign in